The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of abemaciclib (abema) after palbociclib (palbo) in patients (pts) with metastatic breast cancer (MBC).
 
Veronica Mariotti
No Relationships to Disclose
 
Hung T. Khong
Stock and Other Ownership Interests - Apricus Biosciences; Aptose Biosciences; Array BioPharma; Exelixis; Immunomedics; MEI Pharma; Molecular Templates; savara; TG Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly
 
Ricardo L Costa
No Relationships to Disclose
 
Shanel Fisher
No Relationships to Disclose
 
David Boulware
No Relationships to Disclose
 
Hyo S. Han
Consulting or Advisory Role - Pfizer
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); TapImmune Inc. (Inst); Tesaro (Inst)